跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-Alendronate Plus D3 and calcium alendronic acid (as sodium) 70 mg/ colecalciferol 140 ug tablets and 1250 mg calcium carbonate tablets composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-Alendronate Plus D3 and calcium alendronic acid (as sodium) 70 mg/ colecalciferol 140 ug tablets and 1250 mg calcium carbonate tablets composite pack
Approved
STANDARD
APO-Alendronate Plus D3 and calcium alendronic acid (as sodium) 70 mg/ colecalciferol 140 ug tablets and 1250 mg calcium carbonate tablets composite pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3fa8f6d29bbc51a6
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
3fa8f6d29bbc51a6
Product Name
APO-Alendronate Plus D3 and calcium alendronic acid (as sodium) 70 mg/ colecalciferol 140 ug tablets and 1250 mg calcium carbonate tablets composite pack
Artg Id
246777
Artg Name
APO-Alendronate Plus D3 and calcium alendronic acid (as sodium) 70 mg/colecalciferol 140 ug tablets and calcium 500 mg tablets composite pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2016-05-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3fa8f6d29bbc51a6
Type
Standard
Back to TGA Approvals